C

Complement Therapeutics

11 employees

Complement Therapeutics operates as a preclinical stage company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical

Date founded

2020

Funding rounds raised

Total raised

$79M

from 11 investors over 11 rounds

C

Complement Therapeutics raised $79M on April 17, 2023

Investors: Gimv, Hadean Ventures, Forbion, PANAKES, BGV (BioGeneration Ventures), Cambridge Innovation Capital plc and Seroba-Kernel Ltd (Ireland)

C

Complement Therapeutics raised $5.7M on February 23, 2022

Investors: Forbion and BGV (BioGeneration Ventures)

C

Complement Therapeutics raised undisclosed on January 1, 2021

Investors: BGV (BioGeneration Ventures) and Forbion

FAQ